Pca clinical trials

Explore recruiting pca clinical trials.

Recruiting pca studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pca trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Open-Label, Randomized Study of Atezolizumab and Tiragolumab Compared with Durvalumab in Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer who have not Progressed after Concurrent Platinum-Based Chemoradiation (SKYSCRAPER-03)

Poland, Spain, Portugal, Belgium, France, Greece +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBEXELIMAB IN PATIENTS WITH IGG4-RELATED DISEASE (INDIGO)

Spain, Germany, Netherlands, Italy, Sweden, Hungary +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Surgical treatment with or without apalutamide in subjects with high risk prostate cancer who are candidates for radical prostatectomy and staged as oligometastatic with PSMA-PET (STAPLE)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

EORTC-1532-GUCG: A phase 2 Randomized Open-Label Study of Oral darolutamide (ODM-201) vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in Men with Hormone Naive Prostate Cancer.

Italy, Spain, France, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

99mTechnetium and Cyanine-5 (HybriD) Prostate Specific Membrane Antigen (PSMA) Tracer-gUided Surgery in ProstAte Cancer - a FeasibiLity Study (DUAL study)

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

BCS-ORL - Evaluation of the superficial cervical plexus block in oncological throat and neck surgery

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pca trials by city

Pca in Toronto Pca in Vancouver Pca in Montreal Pca in Calgary Pca in Edmonton Pca in Ottawa Pca in Winnipeg Pca in Quebec City Pca in Hamilton Pca in Kitchener Pca in London Pca in Halifax Pca in New York Pca in Los Angeles Pca in Chicago Pca in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease